Source: Υπουργείο Υγείας (CY) Revision Year: 2015 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Kirin 2g powder for suspension for injection.
| Pharmaceutical Form |
|---|
|
Powder for suspension for injection. White or almost white powder for suspension for injection. |
Each vial contains 2g of spectinomycin as spectinomycin dihydrochloride pentahydrate.
| Active Ingredient | Description | |
|---|---|---|
| Spectinomycin |
Spectinomycin is an inhibitor of protein synthesis in the bacterial cell; the site of action is the 30S ribosomal subunit. Spectinomycin is indicated in the treatment of acute gonorrheal urethritis and proctitis in the male and acute gonorrheal cervicitis and proctitis in the female when due to susceptible strains of Neisseria gonorrhoeae. |
| List of Excipients |
|---|
|
None. |
Clear type II glass vials, sealed with stopper and aluminium overcap. Each vial contains the equivalent of 2g spectinomycin as spectinomycin dihydrochloride pentahydrate.
Packs of 1, 10 or 100 vials are available.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
13557
Date of first authorisation: 01/11/ 1991
Date of renewal: 13/06/2013
| Drug | Countries | |
|---|---|---|
| KIRIN | Cyprus, Hong Kong |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
